A-kinase anchoring proteins: CAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases

British Journal of Pharmacology

Volumn 171, Issue 24, 2014, Pages 5603-5623

  Poppinga, W J ^a,b   Munoz Llancao P ^a,b,c   Gonzalez Billault C ^c   Schmidt, M ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN; CAVEOLIN 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 5; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EZRIN; F ACTIN; GLUCOCORTICOID; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE CELL ADHESION MOLECULE; PHOSPHODIESTERASE IV; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN KINASE C; RAC PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; UVOMORULIN; PHOSPHODIESTERASE;

AIRWAY REMODELING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ASTHMA; BINDING SITE; BRAIN CORTEX; CELL COMPARTMENTALIZATION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLEX FORMATION; DEGENERATIVE DISEASE; DOWN REGULATION; ENZYME BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; LEARNING; LUNG ALVEOLUS WALL; MEMORY; MITOCHONDRIAL MEMBRANE; MULTIPLE SCLEROSIS; MYOSITIS; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; UPREGULATION; BRAIN; LUNG; METABOLISM; PHYSIOLOGY;

A KINASE ANCHOR PROTEINS; BRAIN; CELL COMPARTMENTATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; NEURODEGENERATIVE DISEASES; PHOSPHORIC DIESTER HYDROLASES; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 84919372103     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12882     Document Type: Review

References (257)

1. Abel T, Lattal KM, (2001). Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol 11: 180-187.
2. Abel T, Nguyen PV, (2008). Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Prog Brain Res 169: 97-115.
3. Abrams TW, Castellucci VF, Camardo JS, Kandel ER, Lloyd PE, (1984). Two endogenous neuropeptides modulate the gill and siphon withdrawal reflex in Aplysia by presynaptic facilitation involving cAMP-dependent closure of a serotonin-sensitive potassium channel. Proc Natl Acad Sci U S A 81: 7956-7960.
4. Aguilaniu B, (2010). Impact of bronchodilator therapy on exercise tolerance in COPD. Int J Chron Obstruct Pulmon Dis 5: 57-71.
5. Akakura S, Gelman IH, (2012). Pivotal role of AKAP12 in the regulation of cellular adhesion dynamics: control of cytoskeletal architecture, cell migration, and mitogenic signaling. J Signal Transduct 2012: 529179.
6. Akakura S, Huang C, Nelson PJ, Foster B, Gelman IH, (2008). Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Cancer Res 68: 5096-5103.
7. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
8. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ligand -gated ion channels. Br J Pharmacol 170: 1582-1606.
9. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Ion channels. Br J Pharmacol 170: 1607-1675.
10. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d) The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
11. Allen MD, Zhang J, (2006). Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem Biophys Res Commun 348: 716-721.
12. Alto NM, Soderling SH, Hoshi N, Langeberg LK, Fayos R, Jennings PA, et al. (2003). Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring. Proc Natl Acad Sci U S A 100: 4445-4450.
13. Andersen SS, Bi GQ, (2000). Axon formation: a molecular model for the generation of neuronal polarity. Bioessays 22: 172-179.
14. Arnsten AF, Ramos BP, Birnbaum SG, Taylor JR, (2005). Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11: 121-128.
15. Baarsma HA, Menzen MH, Halayko AJ, Meurs H, Kerstjens HA, Gosens R, (2011). beta-Catenin signaling is required for TGF-beta1-induced extracellular matrix production by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 301: L956-L965.
16. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
17. Baisamy L, Jurisch N, Diviani D, (2005). Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem 280: 15405-15412.
18. Barnes PJ, (2008). Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
19. Barnes PJ, (2011). Biochemical basis of asthma therapy. J Biol Chem 286: 32899-32905.
20. Bauman AL, Goehring AS, Scott JD, (2004). Orchestration of synaptic plasticity through AKAP signaling complexes. Neuropharmacology 46: 299-310.
21. Beavo JA, Brunton LL, (2002). Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol 3: 710-718.
22. Bhattacharyya S, Biou V, Xu W, Schluter O, Malenka RC, (2009). A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors. Nat Neurosci 12: 172-181.
23. Biel M, (2009). Cyclic nucleotide-regulated cation channels. J Biol Chem 284: 9017-9021.
24. Billington CK, Penn RB, (2003). Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 4: 2.
25. Billington CK, Ojo OO, Penn RB, Ito S, (2013). cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther 26: 112-120.
26. Bretscher A, Edwards K, Fehon RG, (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599.
27. Burgers PP, Ma Y, Margarucci L, Mackey M, van der Heyden MA, Ellisman M, et al. (2012). A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane. J Biol Chem 287: 43789-43797.
28. Burns-Hamuro LL, Ma Y, Kammerer S, Reineke U, Self C, Cook C, et al. (2003). Designing isoform-specific peptide disruptors of protein kinase A localization. Proc Natl Acad Sci U S A 100: 4072-4077.
29. Buxton IL, Brunton LL, (1983). Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258: 10233-10239.
30. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ, et al. (2009). Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374: 685-694.
31. Cant SH, Pitcher JA, (2005). G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol Biol Cell 16: 3088-3099.
32. Carlson CR, Lygren B, Berge T, Hoshi N, Wong W, Tasken K, et al. (2006). Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem 281: 21535-21545.
33. Castellucci VF, Kandel ER, Schwartz JH, Wilson FD, Nairn AC, Greengard P, (1980). Intracellular injection of the catalytic subunit of cyclic AMP-dependent protein kinase simulates facilitation of transmitter release underlying behavioral sensitization in Aplysia. Proc Natl Acad Sci U S A 77: 7492-7496.
34. Cheepala S, Hulot JS, Morgan JA, Sassi Y, Zhang W, Naren AP, et al. (2013). Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters. Annu Rev Pharmacol Toxicol 53: 231-253.
35. Chen H, Wild C, Zhou X, Ye N, Cheng X, Zhou J, (2013). Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC). J Med Chem 57: 3651-3665.
36. Chen MH, Malbon CC, (2009). G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution. Cell Signal 21: 136-142.
37. Cheng PL, Lu H, Shelly M, Gao H, Poo MM, (2011). Phosphorylation of E3 ligase Smurf1 switches its substrate preference in support of axon development. Neuron 69: 231-243.
38. Cheng X, Ji Z, Tsalkova T, Mei F, (2008). Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 40: 651-662.
39. Cheng YF, Wang C, Lin HB, Li YF, Huang Y, Xu JP, et al. (2010). Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats. Psychopharmacology (Berl) 212: 181-191.
40. Chesik D, Wilczak N, De Keyser J, (2008). IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism. Int J Med Sci 5: 240-243.
41. Chiriva-Internati M, Ferrari R, Yu Y, Hamrick C, Gagliano N, Grizzi F, et al. (2008). AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol 140: 465-468.
42. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, Lee JW, et al. (2004). AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 23: 7095-7103.
43. Chou HY, Howng SL, Cheng TS, Hsiao YL, Lieu AS, Loh JK, et al. (2006). GSKIP is homologous to the Axin GSK3beta interaction domain and functions as a negative regulator of GSK3beta. Biochemistry 45: 11379-11389.
44. Christian F, Szaszak M, Friedl S, Drewianka S, Lorenz D, Goncalves A, et al. (2011). Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem 286: 9079-9096.
45. Coghlan VM, Perrino BA, Howard M, Langeberg LK, Hicks JB, Gallatin WM, et al. (1995). Association of protein-kinase-a and protein-phosphatase-2b with a common anchoring protein. Science 267: 108-111.
46. Colledge M, Dean RA, Scott GK, Langeberg LK, Huganir RL, Scott JD, (2000). Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27: 107-119.
47. Cong M, Perry SJ, Lin FT, Fraser ID, Hu LA, Chen W, et al. (2001). Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem 276: 15192-15199.
48. Conti M, Beavo J, (2007). Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76: 481-511.
49. Corbin JD, Sugden PH, Lincoln TM, Keely SL, (1977). Compartmentalization of adenosine 3:5-monophosphate and adenosine 3:5-monophosphate-dependent protein kinase in heart tissue. J Biol Chem 252: 3854-3861.
50. Courilleau D, Bisserier M, Jullian JC, Lucas A, Bouyssou P, Fischmeister R, et al. (2012). Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac. J Biol Chem 287: 44192-44202.
51. Daaka Y, Luttrell LM, Lefkowitz RJ, (1997). Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91.
52. Damera G, Panettieri RA Jr, (2011). Does airway smooth muscle express an inflammatory phenotype in asthma? Br J Pharmacol 163: 68-80.
53. Davare MA, Avdonin V, Hall DD, Peden EM, Burette A, Weinberg RJ, et al. (2001). A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science 293: 98-101.
54. Dekkers BG, Racke K, Schmidt M, (2013). Distinct PKA and Epac compartmentalization in airway function and plasticity. Pharmacol Ther 137: 248-265.
55. DeMarch Z, Giampa C, Patassini S, Martorana A, Bernardi G, Fusco FR, (2007). Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol Dis 25: 266-273.
56. Depry C, Allen MD, Zhang J, (2011). Visualization of PKA activity in plasma membrane microdomains. Mol Biosyst 7: 52-58.
57. Deshpande DA, Penn RB, (2006). Targeting G protein-coupled receptor signaling in asthma. Cell Signal 18: 2105-2120.
58. Dessauer CW, (2009). Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol Pharmacol 76: 935-941.
59. Dickey BF, Walker JK, Hanania NA, Bond RA, (2010). beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 10: 254-259.
60. Dodge KL, Khouangsathiene S, Kapiloff MS, Mouton R, Hill EV, Houslay MD, et al. (2001). mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J 20: 1921-1930.
61. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, et al. (2005). The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437: 574-578.
62. Dodge-Kafka KL, Bauman A, Kapiloff MS, (2008). A-kinase anchoring proteins as the basis for cAMP signaling. Handb Exp Pharmacol 186: 3-14.
63. Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, et al. (2008). Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis 2: 37-48.
64. Faux MC, Scott JD, (1997). Regulation of the AKAP79-protein kinase C interaction by Ca2+/calmodulin. J Biol Chem 272: 17038-17044.
65. Feinstein WP, Zhu B, Leavesley SJ, Sayner SL, Rich TC, (2012). Assessment of cellular mechanisms contributing to cAMP compartmentalization in pulmonary microvascular endothelial cells. Am J Physiol Cell Physiol 302: C839-C852.
66. Ferrari R, Kelly A, Grizzi F, Yuefei Y, Cobos E, Chiriva-Internati M, (2007). Is AKAP-4 a novel cancer testis antigen for multiple myeloma? J Invest Med 55: S266.
67. Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, et al. (2008). Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 100: 437-442.
68. Fraser ID, Cong M, Kim J, Rollins EN, Daaka Y, Lefkowitz RJ, et al. (2000). Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol 10: 409-412.
69. Gao N, Asamitsu K, Hibi Y, Ueno T, Okamoto T, (2008). AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. J Biol Chem 283: 7834-7843.
70. Gao N, Hibi Y, Cueno M, Asamitsu K, Okamoto T, (2010). A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling. J Biol Chem 285: 28097-28104.
71. Gao S, Wang HY, Malbon CC, (2011a). AKAP12 and AKAP5 form higher-order hetero-oligomers. J Mol Signal 6: 8.
72. Gao S, Wang HY, Malbon CC, (2011b). AKAP5 and AKAP12 form homo-oligomers. J Mol Signal 6: 3.
73. Gelinas JN, Banko JL, Peters MM, Klann E, Weeber EJ, Nguyen PV, (2008). Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus. Learn Mem 15: 403-411.
74. Gelman IH, (2010). Emerging roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis. Genes Cancer 1: 1147-1156.
75. Giampa C, Patassini S, Borreca A, Laurenti D, Marullo F, Bernardi G, et al. (2009). Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease. Neurobiol Dis 34: 450-456.
76. Giampa C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, Fusco FR, (2010). Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS ONE 5: e13417.
77. Giembycz MA, Newton R, (2006). Beyond the dogma: novel beta2-adrenoceptor signalling in the airways. Eur Respir J 27: 1286-1306.
78. Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF, et al. (2003). Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet 12: 497-508.
79. Glantz SB, Amat JA, Rubin CS, (1992). cAMP signaling in neurons: patterns of neuronal expression and intracellular localization for a novel protein, AKAP 150, that anchors the regulatory subunit of cAMP-dependent protein kinase II beta. Mol Biol Cell 3: 1215-1228.
80. Global Initiative for Chronic Obstructive Lung Disease (2010). Global strategy for diagnosis, management, and prevention of COPD (December 2010). Available at: http://www.goldcopd.org/uploads/users/files/GOLDReport-April112011.pdf (accessed 07/14/2014).
81. Gold MG, Lygren B, Dokurno P, Hoshi N, McConnachie G, Tasken K, et al. (2006). Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell 24: 383-395.
82. Gold MG, Stengel F, Nygren PJ, Weisbrod CR, Bruce JE, Robinson CV, et al. (2011). Architecture and dynamics of an A-kinase anchoring protein 79 (AKAP79) signaling complex. Proc Natl Acad Sci U S A 108: 6426-6431.
83. Gold MG, Fowler DM, Means CK, Pawson CT, Stephany JJ, Langeberg LK, et al. (2013). Engineering AKAP-selective regulatory subunits of PKA through structure-based phage selection. J Biol Chem 288: 17111-17121.
84. Gomez LL, Alam S, Smith KE, Horne E, Dell'Acqua ML, (2002). Regulation of A-kinase anchoring protein 79/150-cAMP-dependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin. J Neurosci 22: 7027-7044.
85. Gorski JA, Gomez LL, Scott JD, Dell'Acqua ML, (2005a). Association of an A-kinase-anchoring protein signaling scaffold with cadherin adhesion molecules in neurons and epithelial cells. Mol Biol Cell 16: 3574-3590.
86. Gorski JA, Gomez LL, Scott JD, Dell'Acqua ML, (2005b). Association of an A-kinase-anchoring protein signaling scaffold with cadherin adhesion molecules in neurons and epithelial cells. Mol Biol Cell 16: 3574-3590.
87. Gosens R, Dueck G, Rector E, Nunes RO, Gerthoffer WT, Unruh H, et al. (2007). Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. Am J Physiol Lung Cell Mol Physiol 293: L1348-L1358.
88. Gosens R, Mutawe M, Martin S, Basu S, Bos ST, Tran T, et al. (2008). Caveolae and caveolins in the respiratory system. Curr Mol Med 8: 741-753.
89. Grandoch M, Roscioni SS, Schmidt M, (2010). The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 159: 265-284.
90. Guerra S, (2009). Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol 9: 409-416.
91. Halayko AJ, Tran T, Gosens R, (2008). Phenotype and functional plasticity of airway smooth muscle: role of caveolae and caveolins. Proc Am Thorac Soc 5: 80-88.
92. Halliday G, Robinson SR, Shepherd C, Kril J, (2000). Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27: 1-8.
93. Hallsworth MP, Twort CH, Lee TH, Hirst SJ, (2001). Beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol 132: 729-741.
94. Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, et al. (2010). The safety and efficacy of arformoterol and formoterol in COPD. COPD 7: 17-31.
95. Hanoune J, Defer N, (2001). Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41: 145-174.
96. Hanzal-Bayer MF, Hancock JF, (2007). Lipid rafts and membrane traffic. FEBS Lett 581: 2098-2104.
97. Hara M, Fukui R, Hieda E, Kuroiwa M, Bateup HS, Kano T, et al. (2010). Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. J Neurochem 113: 1046-1059.
98. Hasegawa K, Ono T, Matsushita H, Shimono M, Noguchi Y, Mizutani Y, et al. (2004). A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis. Int J Cancer 108: 86-90.
99. Hayes JS, Brunton LL, Brown JH, Reese JB, Mayer SE, (1979). Hormonally specific expression of cardiac protein kinase activity. Proc Natl Acad Sci U S A 76: 1570-1574.
100. Hayes JS, Brunton LL, Mayer SE, (1980). Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 255: 5113-5119.
101. Hewer RC, Sala-Newby GB, Wu YJ, Newby AC, Bond M, (2011). PKA and Epac synergistically inhibit smooth muscle cell proliferation. J Mol Cell Cardiol 50: 87-98.
102. Hill SJ, Baker JG, (2003). The ups and downs of Gs- to Gi-protein switching. Br J Pharmacol 138: 1188-1189.
103. Hogg JC, Timens W, (2009). The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4: 435-459.
104. Holz GG, Chepurny OG, Schwede F, (2008). Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 20: 10-20.
105. Horvat SJ, Deshpande DA, Yan H, Panettieri RA, Codina J, DuBose TD Jr, et al. (2012). A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle. FASEB J 26: 3670-3679.
106. Hoshi N, Langeberg LK, Scott JD, (2005). Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nat Cell Biol 7: 1066-1073.
107. Houslay MD, (2010). Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci 35: 91-100.
108. Hundsrucker C, Klussmann E, (2008). Direct AKAP-mediated protein-protein interactions as potential drug targets. Handb Exp Pharmacol 186: 483-503.
109. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. (2010). Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138.
110. Hutchins BI, (2010). Competitive outgrowth of neural processes arising from long-distance cAMP signaling. Sci Signal 3: jc1.
111. Ibe BO, Portugal AM, Raj JU, (2006). Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Int Arch Allergy Immunol 139: 225-236.
112. Insel PA, Ostrom RS, (2003). Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol 23: 305-314.
113. Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, et al. (2009). Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 23: 507-517.
114. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, et al. (1999). cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci 19: 7486-7494.
115. Jin Z, Hamilton JP, Yang J, Mori Y, Olaru A, Sato F, et al. (2008). Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol Biomarkers Prev 17: 111-117.
116. Jurado S, Biou V, Malenka RC, (2010). A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression. Nat Neurosci 13: 1053-1055.
117. Kandeel M, Balaha M, Inagaki N, Kitade Y, (2013). Current and future asthma therapies. Drugs Today (Barc) 49: 325-339.
118. Kapiloff MS, Piggott LA, Sadana R, Li J, Heredia LA, Henson E, et al. (2009). An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. J Biol Chem 284: 23540-23546.
119. Karner C, Cates CJ, (2012). Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4): CD008989.
120. Kassel KM, Wyatt TA, Panettieri RA Jr, Toews ML, (2008). Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement. Am J Physiol Lung Cell Mol Physiol 294: L131-L138.
121. Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ, et al. (2008). Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 295: L505-L514.
122. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al. (1998). A family of cAMP-binding proteins that directly activate Rap1. Science 282: 2275-2279.
123. Kelly MP, Stein JM, Vecsey CG, Favilla C, Yang X, Bizily SF, et al. (2009). Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia. Mol Psychiatry 14: 398-415.
124. Keravis T, Lugnier C, (2012). Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br J Pharmacol 165: 1288-1305.
125. Kinderman FS, Kim C, von Daake S, Ma Y, Pham BQ, Spraggon G, et al. (2006). A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Mol Cell 24: 397-408.
126. King CC, Sastri M, Chang P, Pennypacker J, Taylor SS, (2011). The rate of NF-kappaB nuclear translocation is regulated by PKA and A kinase interacting protein 1. PLoS ONE 6: e18713.
127. Kliber A, Lynd LD, Sin DD, (2010). The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Respir Res 11: 56.
128. Klussmann E, Maric K, Wiesner B, Beyermann M, Rosenthal W, (1999). Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem 274: 4934-4938.
129. Kocer SS, Wang HY, Malbon CC, (2012). 'Shaping' of cell signaling via AKAP-tethered PDE4D: probing with AKAR2-AKAP5 biosensor. J Mol Signal 7: 4.
130. Komatsu N, Aoki K, Yamada M, Yukinaga H, Fujita Y, Kamioka Y, et al. (2011). Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol Biol Cell 22: 4647-4656.
131. Kovanich D, van der Heyden MA, Aye TT, van Veen TA, Heck AJ, Scholten A, (2010). Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. Chembiochem 11: 963-971.
132. Lee JH, Johnson PR, Roth M, Hunt NH, Black JL, (2001). ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 280: L1019-L1029.
133. Lefkowitz RJ, Rajagopal K, Whalen EJ, (2006). New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 24: 643-652.
134. Liesker JJ, Wijkstra PJ, Hacken NHT, Koeter GH, Postma DS, Kerstjens HA, (2002). A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 121: 597-608.
135. Liu S, Zhang J, Xiang YK, (2011). FRET-based direct detection of dynamic protein kinase A activity on the sarcoplasmic reticulum in cardiomyocytes. Biochem Biophys Res Commun 404: 581-586.
136. Logue JS, Whiting JL, Scott JD, (2011a). Sequestering Rac with PKA confers cAMP control of cytoskeletal remodeling. Small GTPases 2: 173-176.
137. Logue JS, Whiting JL, Tunquist B, Langeberg LK, Scott JD, (2011b). Anchored protein kinase A recruitment of active Rac GTPase. J Biol Chem 286: 22113-22121.
138. Logue JS, Whiting JL, Tunquist B, Sacks DB, Langeberg LK, Wordeman L, et al. (2011c). AKAP220 protein organizes signaling elements that impact cell migration. J Biol Chem 286: 39269-39281.
139. Lu Y, Lu YS, Shuai Y, Feng C, Tully T, Xie Z, et al. (2007). The AKAP Yu is required for olfactory long-term memory formation in Drosophila. Proc Natl Acad Sci U S A 104: 13792-13797.
140. Lu Y, Zha XM, Kim EY, Schachtele S, Dailey ME, Hall DD, et al. (2011). A kinase anchor protein 150 (AKAP150)-associated protein kinase a limits dendritic spine density. J Biol Chem 286: 26496-26506.
141. Lygren B, Carlson CR, Santamaria K, Lissandron V, McSorley T, Litzenberg J, et al. (2007). AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep 8: 1061-1067.
142. Lynch MJ, Baillie GS, Mohamed A, Li X, Maisonneuve C, Klussmann E, et al. (2005). RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta(2)-adrenergic receptor to activation of ERK in HEK293B2 cells. J Biol Chem 280: 33178-33189.
143. Ma L, Brown M, Kogut P, Serban K, Li X, McConville J, et al. (2011). Akt activation induces hypertrophy without contractile phenotypic maturation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 300: L701-L709.
144. Ma N, Abel T, Hernandez PJ, (2009). Exchange protein activated by cAMP enhances long-term memory formation independent of protein kinase A. Learn Mem 16: 367-370.
145. Maillet M, Robert SJ, Cacquevel M, Gastineau M, Vivien D, Bertoglio J, et al. (2003). Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat Cell Biol 5: 633-639.
146. Malbon CC, Tao J, Shumay E, Wang HY, (2004). AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans 32: 861-864.
147. Martinez M, Fernandez E, Frank A, Guaza C, de la Fuente M, Hernanz A, (1999). Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res 846: 265-267.
148. McCahill AC, Huston E, Li X, Houslay MD, (2008). PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases. Handb Exp Pharmacol 186: 125-166.
149. McGeer PL, McGeer EG, (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21: 195-218.
150. McPhee I, Gibson LC, Kewney J, Darroch C, Stevens PA, Spinks D, et al. (2005). Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease. Biochem Soc Trans 33: 1330-1332.
151. Means CK, Lygren B, Langeberg LK, Jain A, Dixon RE, Vega AL, et al. (2011). An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc Natl Acad Sci U S A 108: E1227-E1235.
152. Meurs H, Gosens R, Zaagsma J, (2008). Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models. Eur Respir J 32: 487-502.
153. Meurs H, Oenema TA, Kistemaker LE, Gosens R, (2013). A new perspective on muscarinic receptor antagonism in obstructive airways diseases. Curr Opin Pharmacol 13: 316-323.
154. Mizuno N, Itoh H, (2009). Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals 17: 42-54.
155. Moita MA, Lamprecht R, Nader K, LeDoux JE, (2002). A-kinase anchoring proteins in amygdala are involved in auditory fear memory. Nat Neurosci 5: 837-838.
156. Morales-Garcia JA, Redondo M, Alonso-Gil S, Gil C, Perez C, Martinez A, et al. (2011). Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS ONE 6: e17240.
157. Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, et al. (2006). A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131: 797-808.
158. Morozov A, Muzzio I, Bourtchouladze R, Van-Strien N, Lapidus K, Yin D, et al. (2003). Rap1 couples cAMP signaling to a distinct pool of p42/44MAPK regulating excitability, synaptic plasticity, learning, and memory. Neuron 39: 309-325.
159. Murray AJ, Shewan DA, (2008). Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration. Mol Cell Neurosci 38: 578-588.
160. Murray AJ, Tucker SJ, Shewan DA, (2009). cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A. J Neurosci 29: 15434-15444.
161. Nagai Y, Miyazaki M, Aoki R, Zama T, Inouye S, Hirose K, et al. (2000). A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo. Nat Biotechnol 18: 313-316.
162. Nauert JB, Klauck TM, Langeberg LK, Scott JD, (1997). Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 7: 52-62.
163. Nijholt I, Ostroveanu A, de Bruyn M, Luiten P, Eisel U, Van der Zee E, (2007). Both exposure to a novel context and associative learning induce an upregulation of AKAP150 protein in mouse hippocampus. Neurobiol Learn Mem 87: 693-696.
164. Nijholt IM, Dolga AM, Ostroveanu A, Luiten PG, Schmidt M, Eisel UL, (2008). Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell Signal 20: 1715-1724.
165. Nunes RO, Schmidt M, Dueck G, Baarsma H, Halayko AJ, Kerstjens HA, et al. (2008). GSK-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. Am J Physiol Lung Cell Mol Physiol 294: L1110-L1118.
166. Oenema TA, Smit M, Smedinga L, Racke K, Halayko AJ, Meurs H, et al. (2012). Muscarinic receptor stimulation augments TGF-beta1-induced contractile protein expression by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 303: L589-L597.
167. Oldenburger A, Maarsingh H, Schmidt M, (2012a). Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung. Pharmaceuticals (Basel) 5: 1291-1331.
168. Oldenburger A, Roscioni SS, Jansen E, Menzen MH, Halayko AJ, Timens W, et al. (2012b). Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease. PLoS ONE 7: e31574.
169. Oldenburger A, Poppinga WJ, Kos F, de Bruin HG, Rijks WF, Heijink IH, et al. (2014). A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette smoke. Am J Physiol Cell Physiol 306: C585-C597.
170. Oliveria SF, Gomez LL, Dell'Acqua ML, (2003). Imaging kinase-AKAP79-phosphatase scaffold complexes at the plasma membrane in living cells using FRET microscopy. J Cell Biol 160: 101-112.
171. Oliveria SF, Dell'Acqua ML, Sather WA, (2007). AKAP79/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling. Neuron 55: 261-275.
172. Ostroveanu A, Van der Zee EA, Dolga AM, Luiten PGM, Eisel ULM, Nijholt IM, (2007). A-kinase anchoring protein 150 in the mouse brain is concentrated in areas involved in learning and memory. Brain Res 1145: 97-107.
173. Ostroveanu A, van der Zee E, Eisel U, Schmidt M, Nijholt I, (2010). Exchange protein activated by cyclic AMP 2 (Epac2) plays a specific and time-limited role in memory retrieval. Hippocampus 20: 1018-1026.
174. Ouyang M, Zhang L, Zhu JJ, Schwede F, Thomas SA, (2008). Epac signaling is required for hippocampus-dependent memory retrieval. Proc Natl Acad Sci U S A 105: 11993-11997.
175. Paintlia AS, Paintlia MK, Singh I, Skoff RB, Singh AK, (2009). Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis. Glia 57: 182-193.
176. Parton RG, del Pozo MA, (2013). Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14: 98-112.
177. Patel HH, Murray F, Insel PA, (2008). G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol 186: 167-184.
178. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
179. Perez-Torres S, Cortes R, Tolnay M, Probst A, Palacios JM, Mengod G, (2003). Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 182: 322-334.
180. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. (2010). Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 363: 1715-1726.
181. Pidoux G, Tasken K, (2010). Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J Mol Endocrinol 44: 271-284.
182. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M, (2003). Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 14: 2181-2191.
183. Qureshi HY, Paudel HK, (2011). Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem 286: 5055-5068.
184. Rabe KF, (2011). Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol 163: 53-67.
185. Rask-Andersen M, Almen MS, Schioth HB, (2011). Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10: 579-590.
186. Razani B, Rubin CS, Lisanti MP, (1999). Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J Biol Chem 274: 26353-26360.
187. Rehmann H, (2013). Epac-inhibitors: facts and artefacts. Sci Rep 3: 3032.
188. Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, et al. (2005). Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac. FEBS Lett 579: 1136-1142.
189. Robertson HR, Gibson ES, Benke TA, Dell'Acqua ML, (2009). Regulation of postsynaptic structure and function by an A-kinase anchoring protein-membrane-associated guanylate kinase scaffolding complex. J Neurosci 29: 7929-7943.
190. Rogers J, (2008). The inflammatory response in Alzheimer's disease. J Periodontol 79: 1535-1543.
191. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477.
192. Roscioni SS, Kistemaker LE, Menzen MH, Elzinga CR, Gosens R, Halayko AJ, et al. (2009). PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells. Respir Res 10: 88.
193. Roscioni SS, Dekkers BG, Prins AG, Menzen MH, Meurs H, Schmidt M, et al. (2011a). cAMP inhibits modulation of airway smooth muscle phenotype via the exchange protein activated by cAMP (Epac) and protein kinase A. Br J Pharmacol 162: 193-209.
194. Roscioni SS, Maarsingh H, Elzinga CR, Schuur J, Menzen M, Halayko AJ, et al. (2011b). Epac as a novel effector of airway smooth muscle relaxation. J Cell Mol Med 15: 1551-1563.
195. Roscioni SS, Prins AG, Elzinga CR, Menzen MH, Dekkers BG, Halayko AJ, et al. (2011). Protein kinase A and the exchange protein directly activated by cAMP (Epac) modulate phenotype plasticity in human airway smooth muscle. Br J Pharmacol 164: 958-969.
196. Rosi S, McGann K, Hauss-Wegrzyniak B, Wenk GL, (2003). The influence of brain inflammation upon neuronal adenosine A2B receptors. J Neurochem 86: 220-227.
197. Rossi EA, Goldenberg DM, Chang CH, (2012a). Complex and defined biostructures with the dock-and-lock method. Trends Pharmacol Sci 33: 474-481.
198. Rossi EA, Goldenberg DM, Chang CH, (2012b). The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structures. Bioconjug Chem 23: 309-323.
199. Rossi EA, Chang CH, Cardillo TM, Goldenberg DM, (2013). Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties. Bioconjug Chem 24: 63-71.
200. Rycroft CE, Heyes A, Lanza L, Becker K, (2012). Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 7: 457-494.
201. Saito T, Sugimoto N, Ohta K, Shimizu T, Ohtani K, Nakayama Y, et al. (2012). Phosphodiesterase inhibitors suppress Lactobacillus casei cell-wall-induced NF-kappaB and MAPK activations and cell proliferation through protein kinase A-or exchange protein activated by cAMP-dependent signal pathway. ScientificWorldJournal 2012: 748572.
202. Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW, (2010). Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS ONE 5: e13058.
203. Sarkar D, Erlichman J, Rubin CS, (1984). Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem 259: 9840-9846.
204. Sastri M, Barraclough DM, Carmichael PT, Taylor SS, (2005). A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci U S A 102: 349-354.
205. Sastri M, Haushalter KJ, Panneerselvam M, Chang P, Fridolfsson H, Finley JC, et al. (2013). A kinase interacting protein (AKIP1) is a key regulator of cardiac stress. Proc Natl Acad Sci U S A 110: E387-E396.
206. Satoh J, Tabunoki H, Arima K, (2009). Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis Markers 27: 239-252.
207. Schafer G, Milic J, Eldahshan A, Gotz F, Zuhlke K, Schillinger C, et al. (2013). Highly functionalized terpyridines as competitive inhibitors of AKAP-PKA interactions. Angew Chem Int Ed Engl 52: 12187-12191.
208. Schmidt M, Dekker FJ, Maarsingh H, (2013). Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol Rev 65: 670-709.
209. Schott M, Grove B, (2013). Receptor-mediated Ca and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin. Cell Signal 25: 2125-2135.
210. Schutsky K, Ouyang M, Thomas S, (2011). Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling. Learn Mem 18: 598-604.
211. Scott JD, Dessauer CW, Tasken K, (2012). Creating order from chaos: cellular regulation by kinase anchoring. Annu Rev Pharmacol Toxicol 53: 187-210.
212. Sehrawat S, Ernandez T, Cullere X, Takahashi M, Ono Y, Komarova Y, et al. (2011). AKAP9 regulation of microtubule dynamics promotes Epac1-induced endothelial barrier properties. Blood 117: 708-718.
213. Sethi S, Mahler DA, Marcus P, Owen CA, Yawn B, Rennard S, (2012). Inflammation in COPD: implications for management. Am J Med 125: 1162-1170.
214. Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, et al. (2005). A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer. Gynecol Oncol 99: 183-188.
215. Shelly M, Lim BK, Cancedda L, Heilshorn SC, Gao H, Poo MM, (2010). Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation. Science 327: 547-552.
216. Shih M, Lin F, Scott JD, Wang HY, Malbon CC, (1999). Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 274: 1588-1595.
217. Sin YY, Edwards HV, Li X, Day JP, Christian F, Dunlop AJ, et al. (2011). Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the beta-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol 50: 872-883.
218. Skroblin P, Grossmann S, Schafer G, Rosenthal W, Klussmann E, (2010). Mechanisms of protein kinase a anchoring. Int Rev Cell Mol Biol 283: 235-330.
219. Smith FD, Langeberg LK, Scott JD, (2006a). The where's and when's of kinase anchoring. Trends Biochem Sci 31: 316-323.
220. Smith FD, Langeberg LK, Scott JD, (2011). Plugging PKA into ERK scaffolds. Cell Cycle 10: 731-732.
221. Smith KE, Gibson ES, Dell'Acqua ML, (2006b). cAMP-dependent protein kinase postsynaptic localization regulated by NMDA receptor activation through translocation of an A-kinase anchoring protein scaffold protein. J Neurosci 26: 2391-2402.
222. Smith KE, Gibson ES, Dell'Acqua ML, (2006c). cAMP-dependent protein kinase postsynaptic localization regulated by NMDA receptor activation through translocation of an A-kinase anchoring protein scaffold protein. J Neurosci 26: 2391-2402.
223. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8: 1051-1058.
224. Sonkusare SK, Kaul CL, Ramarao P, (2005). Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope. Pharmacol Res 51: 1-17.
225. Spina D, (2008). PDE4 inhibitors: current status. Br J Pharmacol 155: 308-315.
226. Srivastava D, Jones K, Woolfrey K, Burgdorf J, Russell T, Kalmbach A, et al. (2012). Social, communication, and cortical structural impairments in Epac2-deficient mice. J Neurosci 32: 11864-11878.
227. Stokka AJ, Mosenden R, Ruppelt A, Lygren B, Tasken K, (2009). The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP. Biochem J 425: 381-388.
228. Su B, Bu Y, Engelberg D, Gelman IH, (2010). SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem 285: 4578-4586.
229. Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC, (2004). Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 279: 4988-4999.
230. Tao J, Malbon CC, (2008). G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal 3: 19.
231. Tao J, Wang HY, Malbon CC, (2003). Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor. EMBO J 22: 6419-6429.
232. Tao J, Wang HY, Malbon CC, (2010). AKAR2-AKAP12 fusion protein 'biosenses' dynamic phosphorylation and localization of a GPCR-based scaffold. J Mol Signal 5: 3.
233. Tasken K, Aandahl EM, (2004). Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84: 137-167.
234. Taylor SS, Zhang P, Steichen JM, Keshwani MM, Kornev AP, (2013). PKA: lessons learned after twenty years. Biochim Biophys Acta 1834: 1271-1278.
235. Theurkauf WE, Vallee RB, (1982). Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2. J Biol Chem 257: 3284-3290.
236. Troger J, Moutty MC, Skroblin P, Klussmann E, (2012). A-kinase anchoring proteins as potential drug targets. Br J Pharmacol 166: 420-433.
237. Tsalkova T, Mei FC, Cheng X, (2012a). A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic amp (epac) antagonists. PLoS ONE 7: e30441.
238. Tsalkova T, Mei FC, Li S, Chepurny OG, Leech CA, Liu T, et al. (2012b). Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc Natl Acad Sci U S A 109: 18613-18618.
239. Tunquist BJ, Hoshi N, Guire ES, Zhang F, Mullendorff K, Langeberg LK, et al. (2008). Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc Natl Acad Sci U S A 105: 12557-12562.
240. Ulfig N, Setzer M, (1999). Expression of a kinase anchoring protein 79 in the human fetal amygdala. Microsc Res Tech 46: 48-52.
241. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M, (2002). Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99: 13217-13221.
242. Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Molken MP, Beeh KM, et al. (2011). Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 364: 1093-1103.
243. Walker JK, Penn RB, Hanania NA, Dickey BF, Bond RA, (2011). New perspectives regarding beta(2)-adrenoceptor ligands in the treatment of asthma. Br J Pharmacol 163: 18-28.
244. Wang C, Yang XM, Zhuo YY, Zhou H, Lin HB, Cheng YF, et al. (2012). The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats. Int J Neuropsychopharmacol 15: 749-766.
245. Wang HY, Tao J, Shumay E, Malbon CC, (2006). G-protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol 85: 643-650.
246. Weisenhaus M, Allen ML, Yang L, Lu Y, Nichols CB, Su T, et al. (2010). Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice. PLoS ONE 5: e10325.
247. Welch EJ, Jones BW, Scott JD, (2010). Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 10: 86-97.
248. Wikman H, Kettunen E, Seppanen JK, Karjalainen A, Hollmen J, Anttila S, et al. (2002). Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21: 5804-5813.
249. Willoughby D, Masada N, Wachten S, Pagano M, Halls ML, Everett KL, et al. (2010). A-kinase anchoring protein 79/150 interacts with adenylyl cyclase type 8 and regulates Ca2+-dependent cAMP synthesis in pancreatic and neuronal systems. J Biol Chem 285: 20328-20342.
250. Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P, (1999). Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824: 300-303.
251. Yan H, Deshpande DA, Misior AM, Miles MC, Saxena H, Riemer EC, et al. (2011). Anti-mitogenic effects of beta-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J 25: 389-397.
252. Yang L, Calingasan NY, Lorenzo BJ, Beal MF, (2008). Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV. Exp Neurol 211: 311-314.
253. Yang Y, Shu X, Liu D, Shang Y, Wu Y, Pei L, et al. (2012). EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73: 774-788.
254. Zaldua N, Gastineau M, Hoshino M, Lezoualc'h F, Zugaza JL, (2007). Epac signaling pathway involves STEF, a guanine nucleotide exchange factor for Rac, to regulate APP processing. FEBS Lett 581: 5814-5818.
255. Zhang J, Ma Y, Taylor SS, Tsien RY, (2001). Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci U S A 98: 14997-15002.
256. Zhang J, Hupfeld CJ, Taylor SS, Olefsky JM, Tsien RY, (2005). Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. Nature 437: 569-573.
257. Zieba BJ, Artamonov MV, Jin L, Momotani K, Ho R, Franke AS, et al. (2011). The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity. J Biol Chem 286: 16681-16692.